238 related articles for article (PubMed ID: 17033534)
1. A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
Suskind DL; Finn L; Wahbeh G; Christie D; Horslen S
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):542-4. PubMed ID: 17033534
[No Abstract] [Full Text] [Related]
2. Ursodeoxycholic acid in the treatment of primary sclerosing cholangitis.
Stiehl A
Ital J Gastroenterol; 1996 Apr; 28(3):178-80. PubMed ID: 8789831
[TBL] [Abstract][Full Text] [Related]
3. Ursodiol for all?
Lee SD; Surawicz CM
Am J Gastroenterol; 2001 Dec; 96(12):3437-8. PubMed ID: 11774966
[No Abstract] [Full Text] [Related]
4. Pathogenesis and medical therapy of primary sclerosing cholangitis.
van Milligen de Wit AW
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135
[No Abstract] [Full Text] [Related]
5. [Primary sclerosing cholangitis with itching treated during pregnancy with ursodeoxycholic acid].
Christensen KL; Andersen BN; Vilstrup H
Ugeskr Laeger; 1997 Nov; 159(48):7151-3. PubMed ID: 9417723
[TBL] [Abstract][Full Text] [Related]
6. [Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk].
MMW Fortschr Med; 2006 Jun; 148(24):42-3. PubMed ID: 16850808
[No Abstract] [Full Text] [Related]
7. The medical management of primary sclerosing cholangitis.
Cullen SN; Chapman RW
Semin Liver Dis; 2006 Feb; 26(1):52-61. PubMed ID: 16496233
[TBL] [Abstract][Full Text] [Related]
8. Future directions in the medical treatment of primary sclerosing cholangitis: the need for combination drug therapy.
Fong DG; Lindor KD
Am J Gastroenterol; 2000 Aug; 95(8):1861-2. PubMed ID: 10950026
[No Abstract] [Full Text] [Related]
9. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
10. The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis.
Wolf JM; Rybicki LA; Lashner BA
Aliment Pharmacol Ther; 2005 Nov; 22(9):783-8. PubMed ID: 16225486
[TBL] [Abstract][Full Text] [Related]
11. Primary sclerosing cholangitis in pregnancy refractory to ursodeoxycholic acid treatment: a case report.
Leftwich H; Fang YM; Borgida A; Crombleholme W
J Reprod Med; 2010; 55(11-12):517-9. PubMed ID: 21291041
[TBL] [Abstract][Full Text] [Related]
12. Medical treatment of primary sclerosing cholangitis with ursodeoxycholic acid.
Chapman RW
Dig Liver Dis; 2003 May; 35(5):306-8. PubMed ID: 12846401
[No Abstract] [Full Text] [Related]
13. Primary sclerosing cholangitis: providing a safe and effective treatment.
Imam MH; Lindor KD
Expert Rev Gastroenterol Hepatol; 2012 Jun; 6(3):255-7. PubMed ID: 22646247
[No Abstract] [Full Text] [Related]
14. Prevention of colon cancer with ursodiol in ulcerative colitis.
Kim HS
Inflamm Bowel Dis; 2001 Aug; 7(3):279-80. PubMed ID: 11515858
[No Abstract] [Full Text] [Related]
15. Medical approaches to primary sclerosing cholangitis.
Kaplan MM
Semin Liver Dis; 1991 Feb; 11(1):56-63. PubMed ID: 2047891
[No Abstract] [Full Text] [Related]
16. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.
Tung BY; Emond MJ; Haggitt RC; Bronner MP; Kimmey MB; Kowdley KV; Brentnall TA
Ann Intern Med; 2001 Jan; 134(2):89-95. PubMed ID: 11177311
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Linares RodrÃguez A
Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():24-38. PubMed ID: 11968340
[No Abstract] [Full Text] [Related]
18. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis.
Pardi DS; Loftus EV; Kremers WK; Keach J; Lindor KD
Gastroenterology; 2003 Apr; 124(4):889-93. PubMed ID: 12671884
[TBL] [Abstract][Full Text] [Related]
19. Looking Into the Crystal Ball: Predicting Non-response to Ursodeoxycholic Acid in Primary Biliary Cholangitis.
Zimmer V; Lammert F
EBioMedicine; 2017 Feb; 15():10-11. PubMed ID: 28007481
[No Abstract] [Full Text] [Related]
20. New therapeutic option with N-acetylcysteine for primary sclerosing cholangitis: two case reports.
Ozdil B; Cosar A; Akkiz H; Sandikci M; Kece C
Am J Ther; 2011 May; 18(3):e71-4. PubMed ID: 20019586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
